TABLE 2.
Pairwise comparison between CMV-ELISPOT and CMV-QuantiFERON assays under different conditionsa
| Type pair |
P value for assay |
|
|---|---|---|
| CMV ELISPOT | CMV QuantiFERON | |
| npreg, sero− vs npreg, sero+ | NS | NS |
| preg, sero+ vs npreg, sero+ | NS | NS |
| preg, sero− vs npreg, sero+ | 0.0004 | 0.0000 |
| Primary infection vs npreg, sero+ | 0.0379 | NS |
| Nonprimary infection vs npreg sero+ | NS | NS |
| preg, sero+ vs npreg, sero− | 0.0070 | 0.0017 |
| preg, sero− vs npreg, sero− | NS | NA |
| Primary infection vs npreg, sero− | 0.0039 | 0.0011 |
| Nonprimary infection vs npreg, sero− | 0.0115 | 0.0026 |
| preg, sero− vs preg, sero+ | 0.0000 | 0.0000 |
| Primary infection vs preg, sero+ | 0.0057 | NS |
| Nonprimary infection vs preg, sero+ | NS | NS |
| Primary infection vs preg, sero− | 0.0000 | 0.0000 |
| Nonprimary infection vs preg, sero− | 0.0000 | 0.0000 |
| Nonprimary infection vs primary infection | 0.0104 | NS |
a
Conditions included pregnancy (preg), nonpregnancy (npreg), and CMV serostatus (sero+, seropositivity; sero−, seronegativity). P value is indicated. NS, not significant (P > 0.05); NA, not assessable.